Component

Tizanidine

Tizanidine. Species, exposure and limitations are retained in each linked claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. CYP1A2 was the predominant tested catalyst of tizanidine metabolism.

    Human cytochrome P450 1A2 → Tizanidine source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/dim-research/14998432.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fa9fa0887ce5587c5c1894fd10a4afa651eac8220683d06745675a72f3e1ba2f", "start_char": 0, "end_char": 1208, "text_sha256": "fa9fa0887ce5587c5c1894fd10a4afa651eac8220683d06745675a72f3e1ba2f"}
    experimental_model
    Human microsomes and recombinant CYP comparison
    exposure
    NADPH-dependent substrate consumption and selective inhibition
    limitations
    Enzyme phenotyping; not a trial of DIM with tizanidine.
    nutrient_topic
    Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect. · 3,3'-Diindolylmethane / DIM
    organism
    Human CYP enzymes
    plain_language
    Tizanidine has a strong pathway connection, while the size and direction of a DIM interaction remain unmeasured.
    primary_references
    [dim-p14998432] Tizanidine is mainly metabolized by cytochrome p450 1A2 in vitro. (2004). https://pubmed.ncbi.nlm.nih.gov/14998432/ DOI: 10.1046/j.1365-2125.2003.02028.x
    tissue_or_cell_type
    Tizanidine metabolism

    Diindolylmethane (DIM): formation, receptor signaling, metabolism and drug interactions (2026-09-17) · lines 779–790

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human microsomes and recombinant CYP comparison · source_derived_draft · unverified_draft

    ### dim-tizanidine-1a2 CYP1A2 was the predominant tested catalyst of tizanidine metabolism. Condition category: normal nutrient_topic: Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect. plain_language: Tizanidine has a strong pathway connection, while the size and direction of a DIM interaction remain unmeasured. organism: Human CYP enzymes tissue_or_cell_type: Tizanidine metabolism experimental_model: Human microsomes and recombinant CYP comparison limitations: Enzyme phenotyping; not a trial of DIM with tizanidine. exposure: NADPH-dependent substrate consumption and selective inhibition evidence_span: {"source_cache": "artifacts/dim-research/14998432.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fa9fa0887ce5587c5c1894fd10a4afa651eac8220683d06745675a72f3e1ba2f", "start_char": 0, "end_char": 1208, "text_sha256": "fa9fa0887ce5587c5c1894fd10a4afa651eac8220683d06745675a72f3e1ba2f"} [dim-p14998432] Tizanidine is mainly metabolized by cytochrome p450 1A2 in vitro. (2004). https://pubmed.ncbi.nlm.nih.gov/14998432/ DOI: 10.1046/j.1365-2125.2003.02028.x
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards